Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever

Authors

Batool Sharifi Mood1, Maliheh Metanat1,*, Roya Alavi Naini1, Masoud Mardani2, Ali Amjadi1
1Infectious Diseases and Tropical Medicine Research Center, Boo-Ali Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
2Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
*Corresponding Author: Infectious Diseases and Tropical Medicine Research Center, Boo-Ali Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran. Email:, malihemetanat@yahoo.com. Email: malihemetanat@yahoo.com

Archives of Clinical Infectious Diseases:Vol. 6, issue Suppl; 27-9
Published online:Nov 30, 2011
Article type:Review Article
How to Cite:Sharifi Mood B, Metanat M, Alavi Naini R, Mardani M, Amjadi A. Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever. Arch Clin Infect Dis. 2011;6(Suppl):. doi:

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is an acute viral hemorrhagic fever caused by the Nairovirus in the family of Bunyaviridae, transmitted to humans by the bite of the Hyalomma tick or by direct contact with blood or tissue of an infected animal or human. CCHF is a severe disease with a high mortality rate ranging from 2% to 70%. Early diagnosis and treatment of CCHF infection is critical to rescue the patients and control the disease. The important approach to treatment of CCHF is based on general supportive measures, monitoring of the patients hematologic and coagulation status, with replacement of cells and other factors as needed, and the prompt use of ribavirin. In this article, we underline current therapeutic approaches to CCHF infection.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Jul
2014
Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies

Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies

Maryam Keshtkar Jahromi

Jahromi MK. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014;1(2):e20310. doi: https://doi.org/10.17795/iji-20310

25
Jan
2014
Crimean-Congo Hemorrhagic Fever: A Reemerging Disease

Crimean-Congo Hemorrhagic Fever: A Reemerging Disease

Maliheh Metanat,
Batool Sharifi Mood,
Salehi Masoud

Metanat M, Sharifi Mood B, Masoud S. Crimean-Congo Hemorrhagic Fever: A Reemerging Disease. Arch Clin Infect Dis. 2014;9(1):e20568. doi: https://doi.org/10.5812/archcid.20568

31
Jan
2012

Crimean-Congo Hemorrhagic Fever

Masoud Mardani

Mardani M. Crimean-Congo Hemorrhagic Fever. Arch Clin Infect Dis. 2012;7(1):. doi:

17
Jun
2019
An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever

An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever

Hamidreza Kouhpayeh

Kouhpayeh H. An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever. Int J Infect. 2019;6(2):e91707. doi: https://doi.org/10.5812/iji.91707

25
Jan
2014
Crimean-Congo Hemorrhagic Fever and Hypertention: A Case Report

Crimean-Congo Hemorrhagic Fever and Hypertention: A Case Report

Maliheh Metanat,
Batool Sharifi-Mood,
Roya Alavi-Naini,
Fatihe Kermansaravi,
Majid Hamzehnezhad

Metanat M, Sharifi-Mood B, Alavi-Naini R, Kermansaravi F, Hamzehnezhad M. Crimean-Congo Hemorrhagic Fever and Hypertention: A Case Report. Arch Clin Infect Dis. 2014;9(1):e20696. doi: https://doi.org/10.5812/archcid.20696

More by these authors

Batool Sharifi MoodPubMedScholar
Maliheh MetanatPubMedScholar
Roya Alavi NainiPubMedScholar
Masoud MardaniPubMedScholar
Ali AmjadiPubMedScholar
Share
Cited by
Metrics